Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

Background The KEYNOTE-966 study demonstrated that pembrolizumab combined with chemotherapy is more effective than chemotherapy alone as first-line treatment for patients with advanced biliary tract ...

Researchers reviewed cancer pain management strategies, including traditional Chinese medicine-based strategies such as acupoint therapies. Chinese researchers explored the role of traditional Chinese ...

Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No medication has been shown to be effective in the prevention or treatment of chemotherapy-induced neurotoxicity.

Chemobrain isn’t a medical diagnosis in itself, but rather a cluster of cognitive issues commonly reported by cancer patients. And though it’s not as visible as the physical scars of cancer ...

Data from non-clinical studies conducted by Osmol show that pre-treatment with OSM-0205 prevents the pathologic damage caused by these chemotherapy agents. About Osmol Therapeutics Osmol Therapeutics ...

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy ...

Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy ... Osmol is completing a financing to initiate a Phase 1 study to advance OSM-0205 into clinical ...

Methods: 115 patients with chemotherapy-induced peripheral neuropathy (for ≥1 month, with average pain rating of ≥4/10 or ECOG sensory neuropathy ≥1/3) were randomized in this double-blind, ...

Cannabinoid 1 (CB1R) and delta opioid receptors (DOR) associate to form heteromers that exhibit distinct pharmacological properties. Not much is known about CB1R-DOR heteromer location or signaling ...